300452.SZ · 山河药辅
China A-shares · RS rating 83 · As of 2026-10-14
| Price | 13.01 CNY |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 80 / 75 / 70 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 40 / 16 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.4% |
| Distance from 52-week high | +22.8% |
| Market cap (USD) | $475.1M |